This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2005 Apr 8;308(5719):203.

doi: 10.1126/science.308.5719.203a.

Does the dose make the poison?

Randall E Harris

PMID: 15821073
DOI: 10.1126/science.308.5719.203a

Comment

Does the dose make the poison?

Randall E Harris. Science. 2005.

. 2005 Apr 8;308(5719):203.

doi: 10.1126/science.308.5719.203a.

Author

Randall E Harris

PMID: 15821073
DOI: 10.1126/science.308.5719.203a

No abstract available

PubMed Disclaimer

Comment on

Drug safety. Gaps in the safety net.
Couzin J. Couzin J. Science. 2005 Jan 14;307(5707):196-8. doi: 10.1126/science.307.5707.196. Science. 2005. PMID: 15653480 No abstract available.

Similar articles

COX-2 inhibitors--lessons in drug safety.
Psaty BM, Furberg CD. Psaty BM, et al. N Engl J Med. 2005 Mar 17;352(11):1133-5. doi: 10.1056/NEJMe058042. Epub 2005 Feb 15. N Engl J Med. 2005. PMID: 15713946 No abstract available.
COX-2 inhibitors--a lesson in unexpected problems.
Drazen JM. Drazen JM. N Engl J Med. 2005 Mar 17;352(11):1131-2. doi: 10.1056/NEJMe058038. Epub 2005 Feb 15. N Engl J Med. 2005. PMID: 15713947 No abstract available.
COX-2 inhibitors: no pain, no heart gain?
[No authors listed] [No authors listed] Harv Heart Lett. 2001 Dec;12(4):2-4. Harv Heart Lett. 2001. PMID: 11751079 Review. No abstract available.
COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.
Ray WA, MacDonald TM, Solomon DH, Graham DJ, Avorn J. Ray WA, et al. Pharmacoepidemiol Drug Saf. 2003 Jan-Feb;12(1):67-70. doi: 10.1002/pds.798. Pharmacoepidemiol Drug Saf. 2003. PMID: 12616850 Review. No abstract available.
Celecoxib shown effective in preventing colon polyps.
Nelson NJ. Nelson NJ. J Natl Cancer Inst. 2006 May 17;98(10):665-7. doi: 10.1093/jnci/djj220. J Natl Cancer Inst. 2006. PMID: 16705118 No abstract available.

See all similar articles

Cited by

Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors.
Harris RE, Beebe-Donk J, Alshafie GA. Harris RE, et al. BMC Cancer. 2006 Jan 30;6:27. doi: 10.1186/1471-2407-6-27. BMC Cancer. 2006. PMID: 16445867 Free PMC article.
Similar reductions in the risk of human colon cancer by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors.
Harris RE, Beebe-Donk J, Alshafie GA. Harris RE, et al. BMC Cancer. 2008 Aug 14;8:237. doi: 10.1186/1471-2407-8-237. BMC Cancer. 2008. PMID: 18702823 Free PMC article.
Reduced risk of human lung cancer by selective cyclooxygenase 2 (COX-2) blockade: results of a case control study.
Harris RE, Beebe-Donk J, Alshafie GA. Harris RE, et al. Int J Biol Sci. 2007 Jun 13;3(5):328-34. doi: 10.7150/ijbs.3.328. Int J Biol Sci. 2007. PMID: 17589567 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
Research Materials
- NCI CPTC Antibody Characterization Program